In his article in the BMJ, “Psychiatry in crisis? Dr. Richard Smith, former editor of the BMJ (British Medical Journal) summarizes the message delivered by several speakers at a meeting also convened in June 2016. This meeting took place in Leiden, the . . . Continue reading →
Johnson & Johnson
May 2016: The State of Psychiatry — Child Psychiatrists at APA Meeting
Child psychiatrists at the annual meeting of the American Psychiatric Association in Atlanta, in May 2016, called for “big solutions to improving child mental health care,” recommending an aggressive drug algorithm approach for children. (Psychiatric News, June 16, 2016) This is a . . . Continue reading →
Jury Finds Johnson & Johnson Violated Consumer Protection Law
Johnson & Johnson officilas made a business decision to decieve doctors by lying about the diabetes risk: “how much commercial liability would we incur if we sent a similar letter about Risperdal”? Continue reading →
Risperdal Linked to Stroke; Zyprexa linked to Diabetes
Risperdal Linked to Stroke; Zyprexa linked to Diabetes Fri, 11 Apr 2003 Two highly promoted, best selling neuroleptic drugs (also called, antipsychotics) are linked to life-threatening drug-induced conditions. The Boston Globe reports (below) that elderly people who are prescribed Risperdal are at . . . Continue reading →
Treating children as young as 4 for bipolar – WSJ
Treating children as young as 4 for bipolar – WSJ Thu, 26 May 2005 A report in The Wall Street Journal should raise serious concerns about the legitimacy of psychiatric diagnosing and drug prescribing for children. The Journal reports that close to . . . Continue reading →
Medication switched for research purposes – patient nearly dies
Medication switched for research purposes – patient nearly dies Tue, 11 Nov 2003 The Boston Globe reports that an investigation by a state oversight agency, “uncovered numerous ethical violations at the Solomon Carter Fuller Mental Health Center by Boston Medical Center physicians . . . Continue reading →
Netracor J & J heart Drug May Raise Risk of Dying
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say . . . Continue reading →
Trial Lawyers Are Taking Aim at the Drug Industry_NYT
Trial Lawyers Are Taking Aim at the Drug Industry_NYT Sun, 18 May 2003 It appears that trial lawyers will produce the results that government oversight agencies–in particular, the FDA–have failed to do. Namely, to protect the public against an increasing number of . . . Continue reading →
Part II– Mental Health Screening: A Form of Child Abuse–Mother Jones
Part II– Mental Health Screening: A Form of Child Abuse–Mother Jones http://www.motherjones.com/news/feature/2005/05/medicating_aliah.html enter subscriber code MJZL6Y Tue, 19 Apr 2005 This is a continuation of the earlier Infomail Re: Mental Health Screening expose by Rob Waters in Mother Jones – A detailed . . . Continue reading →
Antipsychotic Dangers Psychotropic drugs may be bad for your heart/ Clozaril and Zyprexa
Major Health Groups Cite Antipsychotic Dangers Psychotropic drugs may be bad for your heart/ Clozaril and Zyprexa Wed, 23 Mar 2005 Obesity and diabetes are the fastest growing health hazard due to bad nutrition and a sedentary life style. However, diabetes is . . . Continue reading →
Eli Lilly Finances World Health Org (WHO) promoting psychotropic drugs
Eli Lilly Finances World Health Org (WHO) promoting psychotropic drugs Sat, 20 Aug 2005 The credibility of the World Health Organization (WHO) is in doubt since its financial ties to Eli Lilly and Johnson and Johnson. The reach of Big Pharma is indeed all-encompassing. NOTHING written in the . . . Continue reading →
Acting FDA Head Temporarily Drops NCI Duty – WashPost
Acting FDA Head Temporarily Drops NCI Duty – WashPost Sat, 1 Oct 2005 Who is kidding who? The appointment of a long time Bush friend, Dr. Andrew Eschenbach, head of the National Cancer Institue, as acting commissioner of the Food and Drug . . . Continue reading →